Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

AstraZeneca's rare cancer drug Calquence gets US regulatory nod
17 Jan 2025

AstraZeneca's rare cancer drug Calquence gets US regulatory nod

(Sharecast News) - AstraZeneca has announced that its Calquence drug has been approved in the US when used alongside chemoimmunotherapy for patients w...

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China
14 Jan 2025

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Hutchmed (China) Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in China for adult ...

LONDON BROKER RATINGS: Deutsche Bank cuts Direct Line to 'hold'
13 Jan 2025

LONDON BROKER RATINGS: Deutsche Bank cuts Direct Line to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday:

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug
13 Jan 2025

AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug

(Alliance News) - AstraZeneca PLC on Monday said its lung cancer treatment, co-developed with Daiichi Sankyo Co Ltd, is under priority review for appr...

AstraZeneca breast cancer drug Lynparza given green light for NHS use
9 Jan 2025

AstraZeneca breast cancer drug Lynparza given green light for NHS use

(Alliance News) - Patients in England with a form of breast cancer will be offered a new treatment after it was given the green light for NHS use.

Hutchmed China disposes of 45% stake in Shanghai joint venture
2 Jan 2025

Hutchmed China disposes of 45% stake in Shanghai joint venture

(Alliance News) - Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd to GP Health Ser...

London close: Stocks mixed in quiet post-Christmas trade
27 Dec 2024

London close: Stocks mixed in quiet post-Christmas trade

(Sharecast News) - London markets closed on a mixed note Friday in subdued trading, as the ongoing holiday period kept activity light with little news...

LONDON MARKET MIDDAY: Stocks red ahead of US trade balance read
27 Dec 2024

LONDON MARKET MIDDAY: Stocks red ahead of US trade balance read

(Alliance News) - Stock prices in London were mostly lower at midday on Friday as market participants continue digesting US jobless data and unrest in...